After-Hours Buzz: Merck, Saks, Intuit, NetApp & More

Pharmacyclics Inc

RESEARCH ALERT-Infinity Pharma, Pharmacyclics: Goldman starts with neutral - Theflyonthewall.com Tuesday, 7 May 2013 | 6:40 AM ET

*Infinity Pharmaceuticals Inc, Pharmacyclics: Goldman starts with neutral- Theflyonthewall.com.
Abbott to work with J&J on genetic test for leukemia drug Thursday, 21 Feb 2013 | 11:33 AM ET

Feb 21- Abbott Laboratories said on Thursday it was working with Johnson& Johnson to see if a genetic diagnostic test made by Abbott would help to identify patients most likely to benefit from a promising experimental leukemia treatment.
10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook Tuesday, 27 Nov 2012 | 11:36 AM ET

TheStreet.com details the 10 best-performing biopharmaceutical stocks of 2012 and their outlook for 2013.